Related references
Note: Only part of the references are listed.Proteasome inhibitors in multiple myeloma: 10 years later
Philippe Moreau et al.
BLOOD (2012)
Links between mutant p53 and genomic instability
Walter Hanel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Zhao Chen et al.
NATURE (2012)
A multipurpose quality assurance phantom for the small animal radiation research platform (SARRP)
Wilfred Ngwa et al.
PHYSICS IN MEDICINE AND BIOLOGY (2012)
Bortezomib-induced BRCAness sensitizes multiple myeloma cells to PARP inhibitors
Paola Neri et al.
BLOOD (2011)
Bortezomib Induces Nuclear Translocation of IκBα Resulting in Gene-Specific Suppression of NF-κB-Dependent Transcription and Induction of Apoptosis in CTCL
Ashish Juvekar et al.
MOLECULAR CANCER RESEARCH (2011)
Response and Resistance to NF-κB Inhibitors in Mouse Models of Lung Adenocarcinoma
Wen Xue et al.
CANCER DISCOVERY (2011)
RADIATION DOSE-VOLUME EFFECTS IN THE LUNG
Lawrence B. Marks et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Robert Timmerman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naive patients with advanced stage non-small cell lung cancer (NSCLC)
Tianhong Li et al.
LUNG CANCER (2010)
Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer
Martin J. Edelman et al.
LUNG CANCER (2010)
Functional genomics to explore cancer cell vulnerabilities
Kristopher T. Kahle et al.
NEUROSURGICAL FOCUS (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Non-Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways
Silvia Saviozzi et al.
CANCER RESEARCH (2009)
Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma.
Danielle N. Yarde et al.
CANCER RESEARCH (2009)
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Ji Luo et al.
CELL (2009)
Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer A Phase II Southwest Oncology Group Study (S0339)
Angela M. Davies et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
The relationship among tumor architecture, pharmacokinetics, pharmacodynamics, and efficacy of bortezomib in mouse xenograft models
Mark J. Williamson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Pneumonectomy after chemoradiation - The Dana-Farber Cancer Institute/Brigham and Women's Hospital experience
Aaron M. Allen et al.
CANCER (2008)
Death through a tragedy: mitotic catastrophe
H. Vakifahmetoglu et al.
CELL DEATH AND DIFFERENTIATION (2008)
High-resolution, small animal radiation research platform with X-ray tomographic guidance capabilities
John Wong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Kerby Shedden et al.
NATURE MEDICINE (2008)
Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks
Wael Y. Mansour et al.
NUCLEIC ACIDS RESEARCH (2008)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir et al.
NATURE (2007)
Targeting apoptosis in solid tumors:: the role of bortezomib from preclinical to clinical evidence
Antonio Russo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells
Yasuhiro Murakawa et al.
CANCER RESEARCH (2007)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
Proteasome function is required for DNA damage response and Fanconi anemia pathway activation
Celine Jacquemont et al.
CANCER RESEARCH (2007)
A versatile tool for conditional gene expression and knockdown
J Szulc et al.
NATURE METHODS (2006)
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
GB Qiao et al.
BRITISH JOURNAL OF CANCER (2005)
Epidermal growth factor receptor mutations in non-small-cell lung cancer:: Implications for treatment and tumor biology
PA Jänne et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line
MM Mortenson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells
YH Ling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pathways of DNA double-strand break repair during the mammalian cell cycle
K Rothkamm et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint
M Stuschke et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2002)
NF-κB as a therapeutic target in multiple myeloma
T Hideshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Share Paper
